-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Radical prostatectomy for localized prostate cancer can reduce mortality
.
The 29-year follow-up of the SPCG-4 randomized trial showed that compared with observational waiting, radical prostatectomy patients can have an additional 2.
The 29-year follow-up of the SPCG-4 randomized trial showed that patients undergoing surgery can have an extra 2.
Although radical prostatectomy can reduce the mortality of patients with local prostate cancer, there is still insufficient research on the impact of different surgical techniques on mortality
.
However, there is still insufficient research on the impact of different surgical techniques on mortality.
Recently, researchers from Sweden published an article in "Eur Urol", evaluating the function and oncology of robot-assisted laparoscopic prostatectomy (RALP) and open retropubic radical prostatectomy (RRP) after 8 years The result situation
.
Robot-assisted laparoscopic prostatectomy (RALP) and open were evaluated.
The function and oncological results of retropubic radical prostatectomy (RRP) after 8 years
Between 2008 and 2011, researchers conducted a prospective, controlled and non-randomized trial at 14 centers in Sweden, recruiting 4003 patients
.
The functional outcome data of the two operations were evaluated through patient questionnaires before surgery, 12 months and 24 months after surgery, and 8 years
The results of the study found that there was no significant difference in urinary incontinence between RALP and RRP at 8 years after surgery (27% vs 29%; adjusted hazard ratio [aRR] 1.
05, 95% confidence interval [CI] 0.
90-1.
23)
.
The prevalence of erectile dysfunction in the RALP group was significantly lower (66% vs 70%; aRR 0.
Main results of patients 8 years after RALP and RRP
Main results of patients 8 years after RALP and RRPIn summary, compared with RRP, PCSM 8 years after RALP is lower
.
The results confirmed that RALP is safe in oncology
Compared with RRP, PCSM was lower 8 years after RALP
Original source:
Anna Lantz, David Bock, Olof Akre et al.
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up
Leave a message here